| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 08/22/2002 | CA2436789A1 Identification of target-specific folding sites in peptides and proteins |
| 08/21/2002 | EP1233066A2 Peptide vector |
| 08/21/2002 | EP1233025A1 Receptor expression cells and use thereof |
| 08/21/2002 | EP1233021A2 An inhibitor of Beta amyloid cleavage enzyme |
| 08/21/2002 | EP1232183A2 Peptides having antiangiogenic activity |
| 08/21/2002 | EP1232174A1 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 08/20/2002 | US6437098 Genetic engineering; anticarcinogenic agents; side effect reduction |
| 08/20/2002 | US6437095 Method for producing chimeric polypeptides |
| 08/20/2002 | US6437094 Peptido-mimetic compounds containing RGD sequence useful as integrin inhibitors |
| 08/20/2002 | US6436903 Immunomodulating compounds comprising d-isomers of amino acids |
| 08/20/2002 | US6436655 Rapid quantitative measurement of soluble fibrin in opaque body fluids |
| 08/20/2002 | US6436405 Haemophilis influenzae vaccine |
| 08/20/2002 | CA2110055C T cell receptor peptides as therapeutics for immune-related disease |
| 08/20/2002 | CA2059124C Platelet aggregation inhibitors |
| 08/15/2002 | WO2002062969A2 Cellular reprogramming in peptide hydrogel and uses thereof |
| 08/15/2002 | WO2002062961A2 Peptide scaffold encapsulation of tissue cells and uses thereof |
| 08/15/2002 | WO2002062843A2 Modified erythropoietin (epo) with reduced immunogenicity |
| 08/15/2002 | WO2002062842A1 Modified keratinocyte growth factor (kgf) with reduced immunogenicity |
| 08/15/2002 | WO2002062833A2 Modified leptin with reduced immunogenicity |
| 08/15/2002 | WO2002062832A2 Modified human brain-derived neutrophic factor (bdnf) with reduced immunogenicity |
| 08/15/2002 | WO2002062810A2 Linkable sialyl lewis x analogs |
| 08/15/2002 | WO2002062375A1 Modified interleukin-1 receptor antagonist (il-1ra) with reduced immunogenicity |
| 08/15/2002 | WO2002018369A3 Peptidomimetic protease inhibitors |
| 08/15/2002 | WO2002013763A3 Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists |
| 08/15/2002 | WO2001092290A3 Ganesin, an 18-residue cysteine-rich defense peptide from spider and related antinicrobial papdides, their preparation and uses. |
| 08/15/2002 | WO2001044273A3 Receptor-selective somatostatin analogs |
| 08/15/2002 | US20020111461 Peptidomimetic compound for us ein the treatment of diabetes |
| 08/15/2002 | US20020111311 Antibiotics |
| 08/15/2002 | US20020111305 Antiviral peptides |
| 08/15/2002 | US20020110558 For therapy |
| 08/15/2002 | CA2437272A1 Modified erythropoietin (epo) with reduced immunogenicity |
| 08/15/2002 | CA2437270A1 Modified keratinocyte growth factor (kgf) with reduced immunogenicity |
| 08/15/2002 | CA2437265A1 Modified leptin with reduced immunogenicity |
| 08/15/2002 | CA2437263A1 Modified human brain-derived neutrophic factor (bdnf) with reduced immunogenicity |
| 08/15/2002 | CA2437214A1 Modified interleukin-1 receptor antagonist (il-1ra) with reduced immunogenicity |
| 08/14/2002 | EP1230268A2 Heteroclitic analogs of class i epitopes |
| 08/14/2002 | EP1230261A2 Ny-eso-1 nonapeptide derivatives, and uses thereof |
| 08/14/2002 | EP1229965A2 Placental human neurokinin b precursor |
| 08/14/2002 | EP1229790A1 MODULATION OF $g(g)$g(d) T CELLS TO REGULATE AIRWAY HYPERRESPONSIVENESS |
| 08/14/2002 | EP0701448B1 Amplification of the vitamin b 12 uptake system using polymers |
| 08/13/2002 | US6432920 Peptide library |
| 08/13/2002 | US6432680 Sequence and method for genetic engineering of proteins with cell membrane translocating activity |
| 08/13/2002 | CA2257254C Antibiotic producing microbe |
| 08/13/2002 | CA2228265C Methodology to produce, purify and assay polypeptides with the proteolytic activity of the hcv ns3 protease |
| 08/13/2002 | CA2092721C Process for the preparation of c-terminally amidated peptides |
| 08/13/2002 | CA2045594C Immunogenic compositions against gastrin peptides |
| 08/08/2002 | WO2002061114A2 Water-soluble, fluorescent and mobile peptide substrates |
| 08/08/2002 | WO2002061044A2 Synthetic peptide and uses for same |
| 08/08/2002 | WO2002061038A2 Homo-doubly labeled compositions for the detection of enzyme activity in biological samples |
| 08/08/2002 | WO2002060491A2 Stabilization of radiopharmaceutical compositions using a hydrophilic thioether or a hydrophilic 6-hydroxy chroman |
| 08/08/2002 | WO2002043746A3 Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension |
| 08/08/2002 | WO2002014347A3 Method for producing peptide salts, their use, and pharmaceutical preparations containing these peptide salts |
| 08/08/2002 | WO2001092306A3 Therapeutic compounds for ovarian cancer |
| 08/08/2002 | WO2001023604A3 Highly conserved genes and their use to generate probes and primers for detection of microorganisms |
| 08/08/2002 | WO2001008636A8 Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein |
| 08/08/2002 | US20020107202 Complementary peptides for the proline-glycine-proline sequence as antagonists of polymorphonuclear leukocyte chemoattractants; treating alkali-injuried eyes |
| 08/08/2002 | US20020107197 Ligands for G protein coupled receptors and methods of using them |
| 08/08/2002 | US20020107182 Compositions and methods for treatment of sexual dysfunction |
| 08/08/2002 | US20020107181 Novel hepatitis C virus ("HCV") protease inhibitors and pharmaceutical compositions comprising them optionally with viricide ribavirin and interferon |
| 08/08/2002 | US20020106701 Monitoring protein activity in sample; conjugate binding protein to peptide substrate, incubate with protein kinase, measure activity of kinase |
| 08/08/2002 | US20020106648 Detecting preferential particles in sample; obtain sample, incubate with binding particle, detect signal from bound particle |
| 08/08/2002 | US20020106640 Peptide for use in the treatment and prevention of viral infection |
| 08/08/2002 | CA2433880A1 Water-soluble, fluorescent, & electrophoretically mobile peptidic substrates for enzymatic reactions and methods for their use in high-troughput screening_assays |
| 08/08/2002 | CA2432973A1 Homo-doubly labeled compositions for the detection of enzyme activity in biological samples |
| 08/08/2002 | CA2426587A1 Stabilization of radiopharmaceutical compositions using hydrophilic thioethers and hydrophilic 6-hydroxy chromans |
| 08/07/2002 | EP1229122A2 Chimeric isoprenoid synthases and uses thereof |
| 08/07/2002 | EP1229042A1 Cyclic peptides and aids vaccines |
| 08/07/2002 | EP1228203A2 Peptide (virip) which inhibits a circulating virus in humans and the use thereof |
| 08/07/2002 | EP1227829A2 Novel chimeric analgesic peptides |
| 08/07/2002 | CN1362967A Modulators for beta-amyloid peptide aggregation comprising D-amino acids |
| 08/07/2002 | CN1362966A Pseudomycin amide and ester analogs |
| 08/06/2002 | US6429306 Library screening; restriction mapping, cloning, genetic engineering, gene expression; probes for diagnostic kits |
| 08/06/2002 | US6429287 Tumor rejection antigens; cancer diagnosis; activators of cytolysis |
| 08/01/2002 | WO2002059352A2 Methods and means for detecting enzymatic cleavage and linkage reactions |
| 08/01/2002 | WO2002059145A1 Methods for preparing purified lipopeptides |
| 08/01/2002 | WO2002059131A1 Formulation of boronic acid compounds |
| 08/01/2002 | WO2002059130A1 Formulation of boronic acid compounds |
| 08/01/2002 | WO2002058715A1 Prevention of diabetes by administration of gnrh antagonists |
| 08/01/2002 | WO2002058589A2 Agents and methods for promoting bone growth |
| 08/01/2002 | WO2002019986A9 Inducing cellular immune responses to hepatitis b virus using peptide and nucleic acid compositions |
| 08/01/2002 | WO2002009649A8 Cell internalized peptide-drug conjugates |
| 08/01/2002 | WO2002004497A3 Multiple antigenic peptides immunogenic against streptococcus pneumoniae |
| 08/01/2002 | WO2001098367A3 Neuroactive peptides for treatment of hypoxia and related conditions |
| 08/01/2002 | WO2001083554A3 Anti-inflammatory compounds and uses thereof |
| 08/01/2002 | WO2001081325A3 Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising alkyl and aryl alanine p2 moieties |
| 08/01/2002 | WO2001034635A9 Methods and compositions for peptide synthesis |
| 08/01/2002 | WO2001026673A9 Antibiotic-metal complex and methods |
| 08/01/2002 | US20020103363 Promoter derived from phytosulfokine precursor gene |
| 08/01/2002 | US20020103336 Cloning of chicken anemia dna |
| 08/01/2002 | US20020103335 Peptide derivatives |
| 08/01/2002 | US20020103135 Modulating the activity of serine proteases |
| 08/01/2002 | US20020103133 Peptidase-cleavable, targeted antineoplastic drugs and their therapeutic use |
| 08/01/2002 | US20020103132 Administering a neuropeptide of bombesin, gastrin-releasing polypeptide, a neuropeptide having an amino acid C terminus corresponding to Trp-Ala-Val-Gly-His-Leu-Met-NH2 |
| 08/01/2002 | US20020103131 Prevention of diabetes by administration of GnRH antagonists |
| 08/01/2002 | US20020103130 Amino acid sequence RX1ETX2WX3 (SEQ ID NO: ) wherein X1, X2 and X3 are any amino acid |
| 08/01/2002 | US20020102723 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of pancreatic defects |
| 08/01/2002 | US20020102657 Binding protein for use as therapeutic tool in the prevention of Infections disease |
| 08/01/2002 | US20020102265 For diagnosis and imaging of cancer and tumor tissues |
| 08/01/2002 | US20020102235 Novel imidazolidinones as NS3-serine protease inhibitors of hepatitis C virus |
| 08/01/2002 | CA2435124A1 Formulation of boronic acid compounds |